Literature DB >> 11551274

Prevalence of psychiatric disorder in a methadone maintenance population.

T Callaly1, T Trauer, L Munro, G Whelan.   

Abstract

OBJECTIVE: The objective of this study was to examine the prevalence of psychiatric disorders in a group of patients who had recently entered a methadone maintenance programme.
METHOD: A total of 62 patients were interviewed using the Composite International Diagnostic Interview (CIDI) within 6 months of commencing methadone maintenance. The CIDI was used to establish symptoms of psychiatric illness at interview and in the 12 months prior.
RESULTS: In the 12 months prior to interview, 76% of the sample fulfilled ICD-10 criteria for a psychiatric disorder other than substance-use disorder. Over half of the group interviewed fulfilled ICD-10 criteria for an affective disorder, two-thirds fulfilled criteria for an anxiety disorder and just under half fulfilled diagnostic criteria for both an affective disorder and an anxiety disorder in the 12 months prior to interview. At the time of interview, 19% fulfilled ICD-10 diagnostic criteria for a moderate or severe affective disorder. Seventy per cent of males and 89% of females interviewed had a comorbid psychiatric illness. In 71% of the group who had a comorbid psychiatric illness, the onset of psychiatric symptomatology was reported to predate the use of heroin.
CONCLUSION: The prevalence of psychiatric disorder is up to 10 times higher in the population on methadone maintenance than in the general population and is two to three times higher than that found in community surveys of those with a substance-use disorder. These results are consistent with earlier findings and have implications for service planning.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551274     DOI: 10.1080/0004867010060507

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  34 in total

1.  Pain and emotional distress among substance-use patients beginning treatment relative to a representative comparison group.

Authors:  Katharina L Wiest; Jason B Colditz; Kathryn Carr; Victoria J Asphaug; Dennis McCarty; Paul A Pilkonis
Journal:  J Addict Med       Date:  2014 Nov-Dec       Impact factor: 3.702

2.  Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China.

Authors:  Mei Yang; Yanhui Liao; Qiang Wang; Marek C Chawarski; Wei Hao
Journal:  Drug Alcohol Depend       Date:  2015-02-02       Impact factor: 4.492

3.  [Acute pain management in patients with drug dependence syndrome].

Authors:  J Quinlan; F Cox
Journal:  Schmerz       Date:  2018-02-08       Impact factor: 1.107

4.  Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.

Authors:  Alethea Desrosiers; Elena Blokhina; Evgeny Krupitsky; Edwin Zvartau; Richard Schottenfeld; Marek Chawarski
Journal:  Drug Alcohol Depend       Date:  2017-01-23       Impact factor: 4.492

5.  Psychiatric correlates of injection risk behavior among young people who inject drugs.

Authors:  Mary Ellen Mackesy-Amiti; Geri R Donenberg; Lawrence J Ouellet
Journal:  Psychol Addict Behav       Date:  2014-08-18

6.  Prevalence of psychiatric disorders among young injection drug users.

Authors:  Mary E Mackesy-Amiti; Geri R Donenberg; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2012-01-09       Impact factor: 4.492

7.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

8.  Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

Authors:  Krista Lisdahl Medina; Paula K Shear
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

9.  Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.

Authors:  Bradley D Stein; Joshua Mendelsohn; Adam J Gordon; Andrew W Dick; Rachel M Burns; Mark Sorbero; Regina A Shih; Rosalie Liccardo Pacula
Journal:  J Addict Dis       Date:  2016-07-22

10.  Prescription opiate misuse among rural stimulant users in a multistate community-based study.

Authors:  Jennifer R Havens; William W Stoops; Carl G Leukefeld; Thomas F Garrity; Robert G Carlson; Russel Falck; Jichuan Wang; Brenda M Booth
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.